DATA RELEASE: FDA Admits Error over Knee Implants / Contribs from ReGen Biologics to Congressmen Cited

BERKELEY, CA, October 19, 2010--According to an article in the Los Angeles Times, the FDA is admitting to making an error in approving a surgical knee implant called the Menaflex Collagen Scaffold made by Hackensack, N.J.-based ReGen Biologics Inc.

According to the Times, the FDA made the decision to approve the device over the objections of FDA scientists after being pressured by four Democratic Congress members. The article names the members of Congress, all from New Jersey:

A contributions search at MAPLight.org reveals that employees of the company have donated $49,950 to the campaign committees of multiple members of Congress since the 2002 election cycle. Amongst elected members of Congress, the top four recipients of campaign contributions by employees of ReGen Biologics are as follows:

Other recipients include, Rep. William Pascrell, ($2,300) and former Rep. Christopher Shays ($2,000). President Barack Obama received $250 in 2007, when he was still a Senator.

Figures are based on monetary and non-monetary contributions to candidate campaign committees of legislators serving in the 109th, 110th and 111th Congresses for election cycles 2002, 2004, 2006, 2008, 2010. Contributions data provided by the Center for Responsive Politics.

About MapLight:
MapLight is a 501(c)(3) nonprofit, nonpartisan research organization that reveals money's influence on politics. If our work has been helpful to you, please consider supporting us.

Media Contact

Pamela Behrsin
Communications
Office: (510) 868-0894
pamela@maplight.org